Lightcalls.com
 

newly come studies continue to sing...

newly come studies continue to sing the praises of black and recent tea.

According to The Tea Council of the U.S.A., Americans excite more than 2.2 billion gallons of tea each year, enough to fill more than 160000 swimming lakes Our love of tea-drinking is actually a 5,000-year-old tradition, and novel research indicates that a warm lot of tea can do more than nourish your inner man -- it can prevent disease, as well.

Historical value

More than 3000 different kinds of tea (300 in China alone) are made from the same plant, the Camellia sinensis. There are three basic adumbrations of tea produced, depending onward how the leaves are processed

Black tea, the in the greatest degree popular variety in the U is made on allowing the tea leaves to tumult before drying. Oolong tea is solely partially fermented before drying, while verdant tea is not fermented at all. Fermentation encourages the oxidization of catechins (naturally occurring antioxidants) and changes them into theaflavins and thearubigin -- flavonoids which are also highly antioxidative and are responsible for the rich color and flavor of black tea.

For several years, researchers have been looking closely at the antioxidative properties of tea, particularly virid tea. To add to this, a wealth of of the present day findings has surfaced over the last brace years. In September of this year, leading researchers from around the globe gathered for the next to the first International Scientific Symposium on Tea and Human Health to current the latest data on the part tea may play in disease prevention, including its potential to obviate human cancer.



Tea and cancer

The Chinese Academy of Preventative Medicine in Beijing mode of actioned a trial study on the events of black and green tea (given orally and topically) forward subjects diagnosed with pre-cancerous oral lesions. After six month the tea-treated form into groups displayed a marked decrease in confined apartment proliferation, suggesting that tea may inhibit cancer formation (and growth) in humans.

Another inquiry that explored the cancer-inhibiting properties of tea was guarded at the Mayo Clinic earlier this year. Researchers institute that epigallocatechin-3-gallate (EGCG), one of the six catechin polyphenols isolated from recent tea, deters cell growth of human prostate cancer small rooms Numerous animal studies indicate that EGCG stops tumor progression, lowers low-density lipoprotein (LDL) cholesterol horizontals and has tremendous antioxidative capabilities.

modern research at Rutgers University, NJ has revealed that the one and the other black tea and green tea preclude the progression and spontaneous formation of lung tumors in mice.

The merit of these fresh findings has spurred new interest in the olden question of whether or not tea can really retain us healthy. Of special interest is the direct applications tea may have upon a variety of human cancers. While there is still greatly to learn, the data in such a manner far suggest that the polyphenols not absent in tea are capable of binding with cancer-inducing agents, in the same state [i]or[/i] condition as free radicals and peroxides, before they can damage healthy tissue. Studies also indicate that as little as four to five chalices of tea daily may provide enough antioxidative qualities necessary to thwart many diseases.

REFERENCES

Chen, J et al. "The Chemopreventative forces of Tea on Human Precancerous Oral Mucosa Lesions," quick in emergenciesed at the 2nd Annual Scientific Symposium onward Tea and Human Health, Washington, DC tribe 12, 1998.

Higashi-Okai, K et al. "Potent suppressive activity of chlorophyll a and b from fresh tea (Camellia sinensis) against tumor promotion in mouse skin," Sangyo Ika Daigaku Zasshi 20(3):181-8 September 1 1998

Landau, JM et al. "Inhibition of spontaneous formation of lung tumors and rhabdomyosarcomas in A/J mice by the agency of black and green tea," Carcinogenisis 19(3):501-7 March 1998

Paschka, A.G., et al. "Induction of apoptosis in prostate cancer enclosed space lines by the green tea component part (-)-epigallocatechin-3-gallate," Cancer Letters 130(1-2):1-7, August 14 1998

Suganuma, M et al. "Wide distribution of [3H] (-)-epigallocatechin gallate, a cancer preventative tea polyphenol, in mouse tissue," Carcinogenesis 19(10):1771-6 October 1998

Yang, C et al. "Tea and tea polyphenols inhibit small cavity hyperproliferation, lung tumorigenisis, and tumor progression," Experimental Lung Research 24(4):629-39 July/August 1998

COPYRIGHT 1999 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved

COPYRIGHT 2000 Gale Group



Other Articles
 -Morphotek will collaborat...
 -Eksigent Technologies nam...
 -The benefits of outsourci...
 -Sartorius Corporation ...
 -In our previous column, w...
 -Efoora appointed Michael ...
 -Affymax appointed Anne-Ma...
 -Traditionally, continuous...
 -New Brunswick Scientific ...
 -The German-American firm ...
 -Don G. Burstyn, formerly ...
 -American patients are mor...
 -Summary Prior to va...
 -BioPharm Editorial Adviso...
 -Australia agreed to spend...
 -The Biotechnology Industr...
 -Ambion, The RNA Company i...
 -Therapies based on living...
 -A recent survey found tha...
 -ViroLogic will acquire Ac...
 -Cardinal Health named Joh...
 -One of the greatest chall...
 -As the president of a sma...
 -Sweden-based Biovitrum wi...
 -Nanogen appointed David L...
 -The Experion Process Know...
 -Although biomedical resea...
 -The Supreme Court of Cana...
 -Netherlands-based DSM Bio...
 -David A. Smoller joined S...
 -A few months ago, I wrote...
 -Panacos Pharmaceuticals w...
 -Karen K. Vaccaro will res...
 -Acceleron Pharma appointe...
 -Two quarterly meetings of...
 -Illinois-based Abbot Labo...
 -FKI Logistics announced t...
 -The following corrections...
 -It its widest definition,...
 -UK-based Xcellsyz will li...
 -Andrew P. Aromando joined...
 -Invitrogen's comprehensiv...
 -Last month, we described ...
 -The Swiss life sciences c...
 -Protein Design Labs (PDL)...
 -Model It HNMR, the newest...
 -Tech transfer, like chang...
 -QLT and Atrix Laboratorie...
 -Dendreon announced Christ...
 -Baxter Pharmaceutical Sol...
 -The biopharmaceutical ind...
 -GlaxoSmithKline announced...
 -Montreal-based Caprion Ph...
 -Xenova Group recently ann...
 -Cole-Parmer's new 192-pag...
 -Over the last decade ther...
 -Benchmark your facility p...
 -As biotechnology organiza...
 -Frederick D. Sancillo, fo...
 -Insmed acquired a recombi...
 -Baxter Pharmaceutical Sol...
 -Model It HNMR, the newest...
 -DA's regulation 21 CFR Pa...
 -Robert P. Ryan joined Ath...
 -A new report from Busines...
 -Biotest offers a complete...
 -Swagelok offers a brochur...
 -Partnering is a global ph...
 -Human Genome Sciences CEO...
 -Shorten the process devel...
 -The licensure of biotechn...
 -Rodger Currie joined Amge...
 -The GEA Filtration Model ...
 -A multi-channel chemistry...
 -From June 6-9, San Franci...
 -Skanska USA Building Inc....
 -New Brunswick Scientific'...
 -AVI BioPharma appointed P...
 -Ambion, The RNA Company, ...
 -"If you want to be a...
 -Xcellerex appointed Susan...
 -Researchers identified th...
 -Cool Spring Business Park...
 -In October 2003, Shenzhen...
 -Laureate Pharma appointed...
 -After a 6-5 vote by Calif...
 -QSourcing, a service of Q...
 -The recent discovery of &...
 -Affymax added Douglas L. ...
 -USDA recently approved tw...
 -BioPharm International is...
 -Serologicals has released...
 -This document by Shenzhen...
 -Robert Bronstein joined A...
 -Gloucester Gains Fujisawa...
 -With more than 30 years o...
 -Pall's SUPRAdisc II depth...
 -In today's competitive ma...
 -Protein Design Labs repor...
 -Charles A. Rice will repl...
 -AstraZeneca's Faslodex (f...
.
© 2006 Lightcalls.com All rights reserved.